Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Smid

Showing results (61-70 of 128) with videos related to

Pageof 13
Sort By:
Plos One|December 31, 2015
A Method to Correlate mRNA Expression Datasets Obtained from Fresh Frozen and Formalin-Fixed, Paraffin-Embedded Tissue Samples: A Matter of ThresholdsDana A M Mustafa, Anieta M Sieuwerts, Marcel Smid, et al.
Cancer Letters|March 29, 2016
GATA3 mRNA expression, but not mutation, associates with longer progression-free survival in ER-positive breast cancer patients treated with first-line tamoxifen for recurrent diseaseJingjing Liu, Wendy J C Prager-van der Smissen, Maxime P Look, et al.
Neuroendocrinology|January 26, 2017
The mTORC1 Complex Is Significantly Overactivated in SDHX-Mutated ParagangliomasLindsey Oudijk, Thomas Papathomas, Ronald de Krijger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2012
Validation of a radiosensitivity molecular signature in breast cancerSteven A Eschrich, William J Fulp, Yudi Pawitan, et al.
Plos One|March 21, 2015
Vascular pattern analysis for the prediction of clinical behaviour in pheochromocytomas and paragangliomasLindsey Oudijk, Francien van Nederveen, Cécile Badoual, et al.
Proteomics|January 7, 2017
Proteomic characterization of microdissected breast tissue environment provides a protein-level overview of malignant transformationRené B H Braakman, Christoph Stingl, Madeleine M A Tilanus-Linthorst, et al.
Breast Cancer Research and Treatment|February 10, 2015
DC-SCRIPT is a novel regulator of the tumor suppressor gene CDKN2B and induces cell cycle arrest in ERα-positive breast cancer cellsMarleen Ansems, Jonas Nørskov Søndergaard, Anieta M Sieuwerts, et al.
Cancers|April 30, 2021
Circular RNA in Chemonaive Lymph Node Negative Colon Cancer PatientsInge van den Berg, Marcel Smid, Robert R J Coebergh van den Braak, et al.
Nature Communications|September 28, 2021
Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancerDora Hammerl, John W M Martens, Mieke Timmermans, et al.
Biology|August 27, 2021
Transcriptomic Properties of HER2+ Ductal Carcinoma In Situ of the Breast Associate with Absence of Immune CellsMarie Colombe Agahozo, Marcel Smid, Ronald van Marion, et al.
Pageof 13

Showing results (61-70 of 128) with videos related to

Sort By:
Pageof 13
Plos One|December 31, 2015
A Method to Correlate mRNA Expression Datasets Obtained from Fresh Frozen and Formalin-Fixed, Paraffin-Embedded Tissue Samples: A Matter of ThresholdsDana A M Mustafa, Anieta M Sieuwerts, Marcel Smid, et al.
Cancer Letters|March 29, 2016
GATA3 mRNA expression, but not mutation, associates with longer progression-free survival in ER-positive breast cancer patients treated with first-line tamoxifen for recurrent diseaseJingjing Liu, Wendy J C Prager-van der Smissen, Maxime P Look, et al.
Neuroendocrinology|January 26, 2017
The mTORC1 Complex Is Significantly Overactivated in SDHX-Mutated ParagangliomasLindsey Oudijk, Thomas Papathomas, Ronald de Krijger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2012
Validation of a radiosensitivity molecular signature in breast cancerSteven A Eschrich, William J Fulp, Yudi Pawitan, et al.
Plos One|March 21, 2015
Vascular pattern analysis for the prediction of clinical behaviour in pheochromocytomas and paragangliomasLindsey Oudijk, Francien van Nederveen, Cécile Badoual, et al.
Proteomics|January 7, 2017
Proteomic characterization of microdissected breast tissue environment provides a protein-level overview of malignant transformationRené B H Braakman, Christoph Stingl, Madeleine M A Tilanus-Linthorst, et al.
Breast Cancer Research and Treatment|February 10, 2015
DC-SCRIPT is a novel regulator of the tumor suppressor gene CDKN2B and induces cell cycle arrest in ERα-positive breast cancer cellsMarleen Ansems, Jonas Nørskov Søndergaard, Anieta M Sieuwerts, et al.
Cancers|April 30, 2021
Circular RNA in Chemonaive Lymph Node Negative Colon Cancer PatientsInge van den Berg, Marcel Smid, Robert R J Coebergh van den Braak, et al.
Nature Communications|September 28, 2021
Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancerDora Hammerl, John W M Martens, Mieke Timmermans, et al.
Biology|August 27, 2021
Transcriptomic Properties of HER2+ Ductal Carcinoma In Situ of the Breast Associate with Absence of Immune CellsMarie Colombe Agahozo, Marcel Smid, Ronald van Marion, et al.
Pageof 13